Our CEO, Reagan Jarvis, is in Boston for this conference. Reagan is speaking about our standardised cellular assay platforms for the systematic characterisation of off-Target TCR toxicities. Get in touch with us if you would like to connect.
Press release Apr 7, 2022Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca’s Scientific Advisory Board
Södertälje, Sweden, 7th April 2022 – Anocca, a biotechnology company using its precision biology platforms …
Press release Feb 22, 2022Anocca Appoints New Senior Management Roles and Expands Scientific Teams
Södertälje, Sweden, February 22, 2022 – Anocca AB, a pioneer in T cell immunotherapy, today …
Press release Sep 8, 2021Anocca appoints Jacob Michlewicz as CFO
Södertälje, Sweden, 8 September 2021 – Anocca AB, a leader in unlocking the potential of …